CLINICAL_TRIALS
trial_result
· 2021-08-02
Clinical Trial Update: TAK-242 in Patients With Acute Alcoholic Hepatitis [Phase 2]
Summary
Phase 2 clinical trial update for TAK-242 in patients with acute-on-chronic liver failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akaza Bioscience Ltd | Conditions: Acute-On-Chronic Liver Failure | Phase 2 | Status: UNKNOWN